Efficacy of orally administered fluralaner in dogs against laboratory challenge with Haemaphysalis longicornis ticks

Acaricidal activity of Egyptian crude plant extracts against Haemaphysalis longicornis ticks

Haemaphysalis longicornis is a common Ixodida tick species found in temperate areas of Asian countries. An anti-tick assay was conducted on adult female H. longicornis ticks. Plant extract solutions were prepared at concentrations of 50, 25, and 10 mg/mL. Tick survival and mortality were assessed by counting the number of dead and live ticks at 24 h, 48 h, 72 h, and 96 h posttreatment. Out of 11 plant extracts screened, Artemisia judaica extract exhibited the highest potency with 100% mortality (5/5) at 48 h when applied at high and moderate concentrations (50 and 25 mg/mL). Similar results were observed at 96 h for the 10 mg/mL group compared to the untreated ticks. Cleome droserifolia extract demonstrated partial activity with 60% (3/5) and 20% (1/5) mortality at 96 h posttreatment at concentrations of 50 and 25 mg/mL, respectively. Forsskaolea tenacissima extract showed a weak effect with 100% tick mortality (5/5) only at the highest treatment concentration after 96 h. To confirm the activity of A. judaica, trial 2 was conducted. A. judaica demonstrated potency within 48 h in high dose and 72 h in moderate dose, with 100% mortality (15/15) at 96 h posttreatment compared to untreated ticks. The median lethal time 50 (LT50) values were 30.37 h for the high and 55.08 h for the moderate doses. Liquid chromatography‒mass spectrometry was performed on the most potent candidate (A. judaica) to identify its phytochemical components. The results revealed the presence of 9 compounds identified through manual annotation and 74 compounds from the Global Natural Products Social library. These compounds included terpenoids, steroids, phenylpropanoids, flavonoid glycosides, flavonoids, and benzenoids. Camphor was identified as the major component via both approaches. These findings suggest the potential use of A. judaica extract in the future development of acaricidal therapeutics.

Lethal and sublethal effects of fluralaner on the citrus red mite, Panonychus citri (McGregor)

BACKGROUND

The citrus red mite, Panonychus citri (McGregor) is a globally distributed agricultural pest. Of late, resistance to common acaricides has raised concerns that chemical control of P. citri is an inefficient means of control. Fluralaner, a highly toxic isoxazoline insecticide used to treat various ectoparasites, presents one potential alternative. However, little information has been reported about the effect of fluralaner on the citrus red mite. This study aims to evaluate the toxicity, sublethal and transgenerational effects of fluralaner on P. citri.

RESULTS

In both laboratory and field populations of P. citri, we found fluralaner to be more toxic than conventional alternatives, including fenpropathrin, bifenazate, azocyclotin and chlorpyrifos. Interestingly, fluralaner proved more toxic to female adults than to the eggs of P. citri, with median lethal concentrations (LC50) of 2.446 and 122.7 mg L-1, respectively. Exposure to sublethal concentrations of fluralaner (LC10, LC20 and LC30) significantly reduced the fecundity and longevity of female adults P. citri individuals. Although concentrations of fluralaner applied to the parental female adults (F0) led to some changes in the developmental parameters, there were no significant changes in most of the life table parameters or population growth of the F1 generation.

CONCLUSION

Our results indicate that fluralaner is highly toxic to P. citri, and a significant sublethal effect on F0 could suppress the population growth of P. citri, but not for F1. Fluralaner may be considered as a pesticide for the future management of the citrus red mite. © 2024 Society of Chemical Industry.

Efficacy of fluralaner chewable tablets (Bravecto®) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs

BACKGROUND

The parthenogenic reproductive ability of Haemaphysalis longicornis, facilitating quick life cycle completion and rapid geographic spread and its pathogen vector potential make infestations a risk to human and canine health. Two 90-day studies were initiated to evaluate the efficacy of a single fluralaner administration for the treatment and prevention of H. longicornis infestations on dogs.

METHODS

Dogs were randomly assigned (10 dogs/group) to either an untreated control group or a group treated once (Day 0) with 13.64% w/w fluralaner chewable tablets (Bravecto^®) at the minimum label dose rate of 25 mg/kg. Each dog was infested with approximately 50 H. longicornis ticks on Days -9 or -6 and on Days -2, 28, 58 and 88. A different US tick isolate was used in each study. Tick counts were completed on Days -7 or -4, 2, 30, 60 and 90. The primary efficacy criterion was a 90% reduction in arithmetic mean tick counts between the treated and control groups. For between-group comparisons at any assessment, at least six control dogs were required to retain at least 25% of the infestation dose (13 live ticks).

RESULTS

Pre-study infestations demonstrated susceptibility of all study dogs to challenge with H. longicornis. At each subsequent assessment in both studies, at least seven untreated control dogs retained ≥ 25% of the challenge, demonstrating adequate infestations for each efficacy calculation. On Days 2, 30, 60 and 90 the mean live tick infestation rate (number of ticks recovered from each dog/infesting challenge of each dog) of untreated control dogs ranged from 27.8 to 60.8%. No live ticks, free or attached, were found on any fluralaner-treated dog in either study. Between-group differences were statistically significant (P ≤ 0.0002) at each assessment.

CONCLUSION

At the minimum recommended label dose rate of 25 mg/kg, fluralaner chewable tablets were 100% effective in eliminating H. longicornis ticks from dogs infested at the time of treatment. Complete efficacy against both US isolates of this tick was maintained through 90 days following a single treatment. Therefore, fluralaner is a treatment of choice for protecting dogs against this invasive tick species.

Current review of isoxazoline ectoparasiticides used in veterinary medicine

The isoxazolines are a novel class of ectoparasiticides with potent inhibitory activity on glutamate- and gamma-aminobutyric acid-gated chloride channel located in nervous system of invertebrates. In recent years, studies have been performed to evaluate the efficacy and safety of isoxazolines against various types of ectoparasites, including fleas, ticks, and mites. As more single and combined isoxazoline products have been approved by the United States Food and Drug Administration and European Medicines Agency, a more comprehensive understanding of isoxazolines becomes essential for veterinary clinical practitioners. This article provides a complete review of isoxazolines with respect to pharmacodynamics, pharmacokinetics, ectoparasiticidal efficacy, and safety, which will provide veterinarians information to allow them to make the best choice of ectoparasiticide for their clients' specific needs.

A life stage-targeted acaricide application approach for the control of Haemaphysalis longicornis

Haemaphysalis longicornis Neumann is an invasive tick species that has recently been detected in the eastern United States. We designed field studies to monitor the population dynamics of H. longicornis over a year (2019) in New Jersey, and to assess the efficacy of a pyrethroid acaricide (lambda-cyhalothrin) in controlling this tick using a stage-treatment approach. Nymphs were the most abundant life stage found host-seeking from May through early July, followed by a brief period of high adult activity in mid-July, and a very high larval peak extending from late July through October. Overall, 542 adults, 1910 nymphs, and 69,238 larvae were recorded during the sampling. In the present study, the efficacy of acaricide treatments to suppress host-seeking ticks was assessed by applying lambda-cyhalothrin once during each of the three periods of activity for nymphs (June), adults (July), and larvae (August), or sequentially during all three months. Control plots were left untreated and used for phenology studies. Applications in June and July provided 100 % control of all life stages, including the dominant nymphal and adult stages for 42 and 35 d, respectively. Ticks re-established at normal or reduced levels following applications in June or July, respectively, compared to untreated controls. The application in August provided 100 % control for 49 d, and a high level of suppression (>99 % control) remained through the end of the tick season in October. This study therefore supports that single pyrethroid applications can provide 100 % control of H. longicornis for up to 7 wk, and a single late-summer application towards the end of host-seeking adult activity can provide near complete control of the larval population. An evaluation of single applications over the course of the season revealed that treatments in July or August did not lead to significant reductions in the nymphal population. However, multiple sequential treatments targeting all life stages provided 66 %, 97 %, and >99 % control of adults, nymphs, and larvae, respectively through the season of H. longicornis activity.

Haemaphysalis longicornis, the Asian longhorned tick, from a dog in Virginia, USA

The Asian longhorned tick, Haemaphysalis longicornis, was only recently recognized in North America and has since been identified on a wide range of domestic and wild animal hosts in multiple states throughout the eastern United States. An H. longicornis nymph was submitted for identification from a dog in central Virginia, USA. Identification was made using standard keys and confirmed molecularly. No products are currently FDA label-approved as effective for H. longicornis in the USA; however, many acaricides commercially available in the United States are known to be effective against H. longicornis in other areas of the world where this tick is endemic. Veterinarians should be aware H. longicornis can commonly be found infesting dogs, cats, livestock, and wildlife, and should continue recommending year-round tick prevention for all pets and routine monitoring for tick-borne infections.

Efficacy of sarolaner (Simparica®) against induced infestations of Haemaphysalis longicornis on dogs

BACKGROUND

Haemaphysalis longicornis is the major tick affecting dogs in most of the East Asia/Pacific region and has recently been detected in a number of areas of the USA. This tick is a vector for a number of pathogens of dogs, other mammals and humans. In this study, the efficacy of a single oral administration of sarolaner (Simparica^®, Zoetis) at the minimum label dosage (2 mg/kg) was evaluated against an existing infestation of H. longicornis and subsequent weekly reinfestations for 5 weeks after treatment.

METHODS

Sixteen dogs were ranked on pretreatment tick counts and randomly allocated to treatment on Day 0 with sarolaner at 2 mg/kg or a placebo. The dogs were infested with H. longicornis nymphs on Days - 2, 5, 12, 19, 26 and 33. Efficacy was determined at 48 hours after treatment and subsequent re-infestations based on live tick counts relative to placebo-treated dogs.

RESULTS

There were no adverse reactions to treatment. A single dose of sarolaner provided 100% efficacy on Days 2, 7, 14 and 21; and ≥ 97.4% efficacy on Days 28 and 35. Considering only attached, live ticks, efficacy was 100% for the entire 35 days of the study. Geometric mean live tick counts for sarolaner were significantly lower than those for placebo on all days (11.62 ≤ t_(df) ≤ 59.99, where 13.0 ≤ df ≤ 14.1, P < 0.0001).

CONCLUSIONS

In this study, a single oral administration of sarolaner at 2 mg/kg provided 100% efficacy against an existing infestation of H. longicornis nymphs and ≥ 97.4% efficacy (100% against attached ticks) against weekly reinfestation for at least 35 days after treatment.